Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Viviane Fongaro Botosso is active.

Publication


Featured researches published by Viviane Fongaro Botosso.


PLOS Pathogens | 2009

Positive selection results in frequent reversible amino acid replacements in the G protein gene of human respiratory syncytial virus

Viviane Fongaro Botosso; Paolo Marinho de Andrade Zanotto; Mirthes Ueda; Eurico Arruda; Alfredo Elias Gilio; Sandra Elisabete Vieira; Klaus E. Stewien; Teresa Ct Peret; Leda Fátima Jamal; Maria Inês de Moura Campos Pardini; João Renato Rebello Pinho; Eduardo Massad; Osvaldo A. Sant'Anna; Edward C. Holmes; Edison Luiz Durigon

Human respiratory syncytial virus (HRSV) is the major cause of lower respiratory tract infections in children under 5 years of age and the elderly, causing annual disease outbreaks during the fall and winter. Multiple lineages of the HRSVA and HRSVB serotypes co-circulate within a single outbreak and display a strongly temporal pattern of genetic variation, with a replacement of dominant genotypes occurring during consecutive years. In the present study we utilized phylogenetic methods to detect and map sites subject to adaptive evolution in the G protein of HRSVA and HRSVB. A total of 29 and 23 amino acid sites were found to be putatively positively selected in HRSVA and HRSVB, respectively. Several of these sites defined genotypes and lineages within genotypes in both groups, and correlated well with epitopes previously described in group A. Remarkably, 18 of these positively selected tended to revert in time to a previous codon state, producing a “flip-flop” phylogenetic pattern. Such frequent evolutionary reversals in HRSV are indicative of a combination of frequent positive selection, reflecting the changing immune status of the human population, and a limited repertoire of functionally viable amino acids at specific amino acid sites.


Jornal De Pediatria | 2011

Severity of viral coinfection in hospitalized infants with respiratory syncytial virus infection

Milena De Paulis; Alfredo Elias Gilio; Alexandre Archanjo Ferraro; Angela Esposito Ferronato; Patrícia Rossi do Sacramento; Viviane Fongaro Botosso; Danielle Bruna Leal de Oliveira; Juliana Cristina Marinheiro; Charlotte Marianna Hársi; Edison Luiz Durigon; Sandra Elisabete Vieira

OBJECTIVE To compare the severity of single respiratory syncytial virus (RSV) infections with that of coinfections. METHODS A historical cohort was studied, including hospitalized infants with acute RSV infection. Nasopharyngeal aspirate samples were collected from all patients to detect eight respiratory viruses using molecular biology techniques. The following outcomes were analyzed: duration of hospitalization and of oxygen therapy, intensive care unit admission and need of mechanical ventilation. Results were adjusted for confounding factors (prematurity, age and breastfeeding). RESULTS A hundred and seventy six infants with bronchiolitis and/or pneumonia were included in the study. Their median age was 4.5 months. A hundred and twenty one had single RSV infection and 55 had coinfections (24 RSV + adenovirus, 16 RSV + human metapneumovirus and 15 other less frequent viral associations). The four severity outcomes under study were similar in the group with single RSV infection and in the coinfection groups, independently of what virus was associated with RSV. CONCLUSION Virus coinfections do not seem to affect the prognosis of hospitalized infants with acute RSV infection.


The New England Journal of Medicine | 2016

Prolonged Shedding of Zika Virus Associated with Congenital Infection

Danielle Bruna Leal de Oliveira; Flávia J. Almeida; Edison Luiz Durigon; Érica A. Mendes; Carla Torres Braconi; Ivan Marchetti; Robert Andreata-Santos; Marielton dos Passos Cunha; Rúbens Prince dos Santos Alves; Lennon Ramos Pereira; Stella Rezende Melo; Daniel Ferreira de Lima Neto; Flávio da Silva Mesquita; Danielle B. Araujo; Silvana Regina Favoretto; Marco Aurélio Palazzi Sáfadi; Luís Carlos de Souza Ferreira; Paolo Marinho de Andrade Zanotto; Viviane Fongaro Botosso; Eitan Naaman Berezin

In this case report, Zika virus was detected in the bloodstream of an infant who was congenitally infected for at least 2 months after birth.


PLOS ONE | 2012

Phylodynamics and Dispersal of HRSV Entails Its Permanence in the General Population in between Yearly Outbreaks in Children

Hagit Katzov-Eckert; Viviane Fongaro Botosso; Eurico Arruda Neto; Paolo Marinho de Andrade Zanotto

Background Human respiratory syncytial virus (HRSV) is one of the major etiologic agents of respiratory tract infections among children worldwide. Methodology/Principal Findings Here through a comprehensive analysis of the two major HRSV groups A and B (n = 1983) which comprise of several genotypes, we present a complex pattern of population dynamics of HRSV over a time period of 50 years (1956–2006). Circulation pattern of HRSV revealed a series of expansions and fluctuations of co-circulating lineages with a predominance of HRSVA. Positively selected amino acid substitutions of the G glycoprotein occurred upon population growth of GB3 with a 60-nucleotide insertion (GB3 Insert), while other genotypes acquired substitutions upon both population growth and decrease, thus possibly reflecting a role for immune selected epitopes in linkage to the traced substitution sites that may have important relevance for vaccine design. Analysis evidenced the co-circulation and predominance of distinct HRSV genotypes in Brazil and suggested a year-round presence of the virus. In Brazil, GA2 and GA5 were the main culprits of HRSV outbreaks until recently, when the GB3 Insert became highly prevalent. Using Bayesian methods, we determined the dispersal patterns of genotypes through several inferred migratory routes. Conclusions/Significance Genotypes spread across continents and between neighboring areas. Crucially, genotypes also remained at any given region for extended periods, independent of seasonal outbreaks possibly maintained by re-infecting the general population.


Emerging Infectious Diseases | 2018

Yellow Fever Virus DNA in Urine and Semen of Convalescent Patient, Brazil

Carla Meneguin Barbosa; Nicholas Di Paola; Marielton dos Passos Cunha; Mônica J. Rodrigues-Jesus; Danielle B. Araujo; Vanessa Silveira; Fabyano B. Leal; Flávio da Silva Mesquita; Viviane Fongaro Botosso; Paolo Marinho de Andrade Zanotto; Edison Luiz Durigon; Marcos V. Silva; Danielle Bruna Leal de Oliveira

Yellow fever virus RNA is usually detected in blood of infected humans. We detected virus RNA in urine and semen samples from a convalescent patient. A complete virus genome was sequenced for an isolate from a urine sample. This virus had a South American I genotype and unique synapomorphic changes.


Virus Research | 2012

Molecular epidemiology of the SH (small hydrophobic) gene of human respiratory syncytial virus (HRSV), over 2 consecutive years

Hildener Nogueira Lima; Viviane Fongaro Botosso; Danielle Bruna Leal de Oliveira; Angélica Cristine de Almeida Campos; Andréa Lima Leal; Tereza Souza Silva; Patrícia Alves Ramos Bosso; Claudia T. P. Moraes; Claudionor Gomes da Silva Filho; Sandra Elisabete Vieira; Alfredo Elias Gilio; Klaus E. Stewien; Edison Luiz Durigon

Human respiratory syncytial virus (HRSV) strains were isolated from nasopharyngeal aspirates collected from 965 children between 2004 and 2005, yielding 424 positive samples. We sequenced the small hydrophobic protein (SH) gene of 117 strains and compared them with other viruses identified worldwide. Phylogenetic analysis showed a low genetic variability among the isolates but allowed us to classify the viruses into different genotypes for both groups, HRSVA and HRSVB. It is also shown that the novel BA-like genotype was well segregated from the others, indicating that the mutations are not limited to the G gene.


Influenza and Other Respiratory Viruses | 2013

Respiratory syncytial virus epidemic periods in an equatorial city of Brazil

Fernanda E. A. Moura; Anne C. B. Perdigão; Joyce Fonteles Ribeiro; Caroline Mary Gurgel Dias Florêncio; Francisco S. Oliveira; Samuel A. R. Pereira; Viviane Fongaro Botosso; Marilda M. Siqueira; Luciano M. Thomazelli; Raquel Negrão Caldeira; Danielle Bruna Leal de Oliveira; Edison Luiz Durigon

Characterization of the human respiratory syncytial virus (HRSV) season at the local level has important implications for appropriate decisions on the time period for administration of specific prophylaxis.


Brazilian Journal of Microbiology | 2007

Comparison between ectodomain and G2 region of G glycoprotein for genotyping of HRSV

Angélica Cristine de Almeida Campos; Edison Luiz Durigon; Andréa Lima Leal; Tereza Souza Silva; Patrícia Alves Ramos Bosso; Claudia Trigo Pedroso de Moraes; Danielle Bruna Leal de Oliveira; Hildener Nogueira Lima; Sandra Elisabete Vieira; Viviane Fongaro Botosso; Paolo Marinho de Andrade Zanotto; Klaus E. Stewien

The Human Respiratory Syncytial Virus (HRSV), isolated in 1955, is the main cause of hospitalization of babies and infants with respiratory illness. Several studies have been conducted worldwide aiming the development of a safe and effective vaccine against HRSV. The G2 region of glycoprotein G is used as genotyping default. In the present study, we performed a phylogenetic analysis of G protein and a comparative study between G2 region and ectodomain of attachment glycoprotein. Fifty-three nasal swab samples from children less than 5 years old and presenting symptoms of acute respiratory illness, assisted at the University Hospital (UH) of University of Sao Paulo (USP) in 2004, were submitted to sequencing by PCR and compared with GenBank sequences. We concluded that the G2 region is adequate for HRSV genotyping.


Jornal De Pediatria | 2017

Rapid antigen detection test for respiratory syncytial virus diagnosis as a diagnostic tool

Flávio da Silva Mesquita; Danielle Bruna Leal de Oliveira; Daniela Crema; Célia Miranda Nunes Pinez; Thaís Cristina Colmanetti; Luciano Matsumia Thomazelli; Alfredo Elias Gilio; Sandra Elisabeth Vieira; Marina Baquerizo Martinez; Viviane Fongaro Botosso; Edison Luiz Durigon

Objective The aim of this study was to evaluate the QuickVue® RSV Test Kit (QUIDEL Corp, CA, USA) as a screening tool for respiratory syncytial virus in children with acute respiratory disease in comparison with the indirect immunofluorescence assay as gold standard. In Brazil, rapid antigen detection tests for respiratory syncytial virus are not routinely utilized as a diagnostic tool, except for the diagnosis of dengue and influenza.OBJECTIVE The aim of this study was to evaluate the QuickVue® RSV Test Kit (QUIDEL Corp, CA, USA) as a screening tool for respiratory syncytial virus in children with acute respiratory disease in comparison with the indirect immunofluorescence assay as gold standard. In Brazil, rapid antigen detection tests for respiratory syncytial virus are not routinely utilized as a diagnostic tool, except for the diagnosis of dengue and influenza. METHODS The authors retrospectively analyzed 486 nasopharyngeal aspirate samples from children under age 5 with acute respiratory infection, between December 2013 and August 2014, the samples were analyzed by indirect immunofluorescence assay and QuickVue® RSV Test kit. Samples with discordant results were analyzed by real time PCR and nucleotide sequencing. RESULTS From 313 positive samples by immunofluorescence assays, 282 (90%) were also positive by the rapid antigen detection test, two were positive only by rapid antigen detection test, 33 were positive only by immunofluorescence assays, and 171 were positive by both methods. The 35 samples with discordant results were analyzed by real time PCR; the two samples positive only by rapid antigen detection test and the five positive only by immunofluorescence assays were also positive by real time PCR. There was no relation between the negativity by QuickVue® RSV Test and viral load or specific strain. The QuickVue® RSV Test showed sensitivity of 90%, specificity of 98.8%, predictive positive value of 99.3%, and negative predictive value of 94.6%, with accuracy of 93.2% and agreement κ index of 0.85 in comparison to immunofluorescence assay. CONCLUSIONS This study demonstrated that the QuickVue® RSV Test Kit can be effective in early detection of Respiratory syncytial virus in nasopharyngeal aspirate and is reliable for use as a diagnostic tool in pediatrics.


Jornal De Pediatria | 2017

Original articleRapid antigen detection test for respiratory syncytial virus diagnosis as a diagnostic toolTeste rápido de detecção de antígenos para o diagnóstico do Vírus Sincicial Respiratório como ferramenta de diagnóstico

Flávio da Silva Mesquita; Danielle Bruna Leal de Oliveira; Daniela Crema; Célia Miranda Nunes Pinez; Thaís Cristina Colmanetti; Luciano Matsumia Thomazelli; Alfredo Elias Gilio; Sandra Elisabeth Vieira; Marina Baquerizo Martinez; Viviane Fongaro Botosso; Edison Luiz Durigon

Objective The aim of this study was to evaluate the QuickVue® RSV Test Kit (QUIDEL Corp, CA, USA) as a screening tool for respiratory syncytial virus in children with acute respiratory disease in comparison with the indirect immunofluorescence assay as gold standard. In Brazil, rapid antigen detection tests for respiratory syncytial virus are not routinely utilized as a diagnostic tool, except for the diagnosis of dengue and influenza.OBJECTIVE The aim of this study was to evaluate the QuickVue® RSV Test Kit (QUIDEL Corp, CA, USA) as a screening tool for respiratory syncytial virus in children with acute respiratory disease in comparison with the indirect immunofluorescence assay as gold standard. In Brazil, rapid antigen detection tests for respiratory syncytial virus are not routinely utilized as a diagnostic tool, except for the diagnosis of dengue and influenza. METHODS The authors retrospectively analyzed 486 nasopharyngeal aspirate samples from children under age 5 with acute respiratory infection, between December 2013 and August 2014, the samples were analyzed by indirect immunofluorescence assay and QuickVue® RSV Test kit. Samples with discordant results were analyzed by real time PCR and nucleotide sequencing. RESULTS From 313 positive samples by immunofluorescence assays, 282 (90%) were also positive by the rapid antigen detection test, two were positive only by rapid antigen detection test, 33 were positive only by immunofluorescence assays, and 171 were positive by both methods. The 35 samples with discordant results were analyzed by real time PCR; the two samples positive only by rapid antigen detection test and the five positive only by immunofluorescence assays were also positive by real time PCR. There was no relation between the negativity by QuickVue® RSV Test and viral load or specific strain. The QuickVue® RSV Test showed sensitivity of 90%, specificity of 98.8%, predictive positive value of 99.3%, and negative predictive value of 94.6%, with accuracy of 93.2% and agreement κ index of 0.85 in comparison to immunofluorescence assay. CONCLUSIONS This study demonstrated that the QuickVue® RSV Test Kit can be effective in early detection of Respiratory syncytial virus in nasopharyngeal aspirate and is reliable for use as a diagnostic tool in pediatrics.

Collaboration


Dive into the Viviane Fongaro Botosso's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge